Free Trial

20 Stocks Wall Street Analysts Love the Most

Every trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equities research analysts. There are between 300 and 500 brokerages and research houses that issue ratings, price targets and recommendations and more than 5,000 securities around the world that regularly receive coverage from research analysts.

MarketBeat has tracked more than 170,000 distinct analyst recommendations in the last 12 months alone. Given the volume of ratings changes that occur each day, it can be difficult to sift through the noise.

Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when more than a dozen different analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same stock.

This slide show lists the 20 companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

#1 - Fresenius Medical Care (NYSE:FMS)

Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$25.30 (3.0% Upside)

About Fresenius Medical Care

Fresenius Medical Care logoFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. More about Fresenius Medical Care
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/6/2025Truist FinancialBoost Price TargetHold ➝ Hold$23.00 ➝ $25.00
12/2/2024Bank of AmericaUpgradeUnderperform ➝ Neutral
11/6/2024Berenberg BankInitiated CoverageBuy$25.60
10/7/2024Truist FinancialBoost Price TargetHold ➝ Hold$22.00 ➝ $23.00
7/31/2024Truist FinancialLower Price TargetHold ➝ Hold$24.00 ➝ $22.00
5/15/2024Truist FinancialBoost Price TargetHold ➝ Hold$21.00 ➝ $24.00
1/8/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight
11/24/2023HSBCUpgradeReduce ➝ Hold
11/17/2023Societe GeneraleUpgradeHold ➝ Buy
10/11/2023Truist FinancialLower Price TargetHold ➝ Hold$28.00 ➝ $24.00

#2 - Amdocs (NASDAQ:DOX)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$101.20 (10.0% Upside)

About Amdocs

Amdocs logoAmdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. More about Amdocs
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/14/2024BarclaysLower Price TargetOverweight ➝ Overweight$113.00 ➝ $111.00
11/13/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$98.00 ➝ $105.00
10/2/2024Stifel NicolausInitiated CoverageBuy$100.00
5/9/2024CitigroupLower Price TargetBuy ➝ Buy$105.00 ➝ $100.00
5/9/2024Robert W. BairdLower Price TargetNeutral ➝ Neutral$97.00 ➝ $90.00
2/8/2024BarclaysBoost Price TargetOverweight ➝ Overweight$105.00 ➝ $115.00
1/17/2024CitigroupBoost Price TargetBuy ➝ Buy$96.00 ➝ $104.00
12/1/2023Jefferies Financial GroupInitiated CoverageBuy$105.00
8/3/2023OppenheimerBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $109.00
6/16/2023Bank of AmericaBoost Price Target$100.00 ➝ $110.00

#3 - Kinross Gold (NYSE:KGC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
5 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$11.63 (6.9% Downside)

About Kinross Gold

Kinross Gold logoKinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. The company operates the Fort Knox mine and the Manh Choh project in Alaska, as well as the Round Mountain and the Bald Mountain mines in Nevada, the United States; the Paracatu mine in Brazil; the La Coipa and the Lobo-Marte project in Chile; the Tasiast mine in Mauritania; and the Great Bear project in Canada. More about Kinross Gold
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/21/2025National Bank FinancialUpgradeStrong-Buy
3/19/2025Stifel CanadaUpgradeStrong-Buy
2/13/2025CIBCBoost Price TargetOutperform$13.00 ➝ $14.00
10/4/2024Jefferies Financial GroupBoost Price TargetHold ➝ Hold$9.00 ➝ $10.00
8/19/2024ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$9.50 ➝ $11.00
7/12/2024Jefferies Financial GroupBoost Price TargetHold ➝ Hold$7.00 ➝ $9.00
7/10/2024CIBCBoost Price TargetOutperformer ➝ Outperformer$8.15 ➝ $12.00
5/23/2024ScotiabankBoost Price TargetSector Outperform ➝ Outperform$8.00 ➝ $9.50
5/21/2024BMO Capital MarketsBoost Price TargetOutperform$10.00 ➝ $11.50
5/9/2024CormarkUpgradeHold ➝ Moderate Buy

#4 - Alamos Gold (NYSE:AGI)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$26.06 (2.3% Downside)

About Alamos Gold

Alamos Gold logoAlamos Gold Inc engages in the acquisition, exploration, development, and extraction of precious metals in Canada and Mexico. The company primarily explores for gold deposits. It holds 100% interest in the Young-Davidson mine and Island Gold mine located in the Ontario, Canada; Mulatos mine located in the Sonora, Mexico; and Lynn Lake project situated in the Manitoba, Canada. More about Alamos Gold
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/21/2025National Bank FinancialUpgradeStrong-Buy
2/11/2025Royal Bank of CanadaBoost Price TargetOutperform$25.00 ➝ $27.00
12/3/2024National Bank FinancialUpgradeSector Perform ➝ Outperform
10/4/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$23.00 ➝ $28.00
9/13/2024Jefferies Financial GroupBoost Price TargetBuy$21.00 ➝ $23.00
9/10/2024Royal Bank of CanadaBoost Price TargetOutperform$20.00 ➝ $23.00
9/8/2024National Bank FinancialDowngradeStrong-Buy ➝ Hold
8/19/2024ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$20.00 ➝ $22.00
7/16/2024ScotiabankBoost Price TargetSector Outperform ➝ Outperform$16.00 ➝ $20.00
7/12/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$20.00 ➝ $21.00

#5 - SS&C Technologies (NASDAQ:SSNC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$97.50 (16.6% Upside)

About SS&C Technologies

SS&C Technologies logoSS&C Technologies Holdings, Inc engages in the development and provision of software solutions to the financial services and healthcare industries. It operates through the following geographical segments: United States, Europe, Middle East and Africa, Asia Pacific and Japan, Canada, and the Americas, excluding the United States and Canada. More about SS&C Technologies
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
2/10/2025DA DavidsonBoost Price TargetBuy ➝ Buy$92.00 ➝ $102.00
2/7/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$86.00 ➝ $96.00
2/7/2025Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$85.00 ➝ $95.00
2/7/2025Needham & Company LLCBoost Price TargetBuy ➝ Buy$90.00 ➝ $105.00
2/3/2025UBS GroupBoost Price TargetBuy ➝ Buy$92.00 ➝ $93.00
2/3/2025Jefferies Financial GroupUpgradeHold ➝ Buy$70.00 ➝ $94.00
10/25/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$79.00 ➝ $85.00
10/25/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$90.00 ➝ $90.00
10/10/2024DA DavidsonReiterated RatingBuy ➝ Buy$92.00 ➝ $92.00
9/20/2024DA DavidsonBoost Price TargetBuy ➝ Buy$88.00 ➝ $92.00

#6 - Itaú Unibanco (NYSE:ITUB)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$6.27 (12.1% Upside)

About Itaú Unibanco

Itaú Unibanco logoItaú Unibanco Holding SA offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. More about Itaú Unibanco
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/17/2025UBS GroupUpgradeNeutral ➝ Buy
1/13/2025Hsbc Global ResUpgradeStrong-Buy
1/13/2025HSBCUpgradeHold ➝ Buy$6.18
11/7/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$7.27 ➝ $6.36
8/22/2024UBS GroupDowngradeBuy ➝ Neutral
6/17/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight
1/16/2024Bank of AmericaUpgradeNeutral ➝ Buy$7.27
1/8/2024HSBCDowngradeBuy ➝ Hold
10/16/2023Jefferies Financial GroupInitiated CoverageHold$5.55
5/19/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight

#7 - MINISO Group (NYSE:MNSO)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
5 Buy Ratings, 1 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$26.03 (33.3% Upside)

About MINISO Group

MINISO Group logoMINISO Group Holding Limited, an investment holding company, engages in the retail and wholesale of lifestyle products and pop toy products in China, Asia, the United States, and Europe. The company offers products in various categories, including home decor products, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care products, snacks, fragrances and perfumes, and stationeries and gifts under the MINISO and WonderLife brand names; and blind boxes, toy bricks, model figures, model kits, collectible dolls, Ichiban Kuji, sculptures, and other popular toys under the TOP TOY brand. More about MINISO Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/25/2025JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$15.00 ➝ $22.00
2/26/2025Hsbc Global ResUpgradeStrong-Buy
2/26/2025HSBCInitiated CoverageBuy$29.30
10/4/2024CitigroupInitiated CoverageBuy$26.80
9/24/2024Dbs BankUpgradeStrong-Buy
9/24/2024JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$27.00 ➝ $15.00
9/23/2024Jefferies Financial GroupReiterated RatingBuy ➝ Hold
9/23/2024Bank of AmericaDowngradeBuy ➝ Underperform
9/3/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$29.00 ➝ $27.00
4/30/2024JPMorgan Chase & Co.Initiated CoverageOverweight$30.00

#8 - Jones Lang LaSalle (NYSE:JLL)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$309.00 (23.0% Upside)

About Jones Lang LaSalle

Jones Lang LaSalle logoJones Lang LaSalle Incorporated operates as a commercial real estate and investment management company. It engages in the buying, building, occupying, managing, and investing in a commercial, industrial, hotel, residential, and retail properties in Americas, Europe, the Middle East, Africa, and the Asia Pacific. More about Jones Lang LaSalle
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/24/2025Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$317.00 ➝ $320.00
12/16/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$263.00 ➝ $327.00
12/10/2024Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$292.00 ➝ $325.00
12/6/2024The Goldman Sachs GroupInitiated CoverageBuy$352.00
11/25/2024Wolfe ResearchUpgradePeer Perform ➝ Outperform$353.00
11/12/2024Keefe, Bruyette & WoodsBoost Price TargetMarket Perform ➝ Market Perform$280.00 ➝ $292.00
8/8/2024Keefe, Bruyette & WoodsBoost Price TargetMarket Perform ➝ Market Perform$240.00 ➝ $250.00
7/25/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$246.00 ➝ $268.00
7/25/2024Keefe, Bruyette & WoodsBoost Price TargetMarket Perform ➝ Market Perform$200.00 ➝ $240.00
7/3/2024UBS GroupBoost Price TargetBuy ➝ Buy$225.00 ➝ $240.00

#9 - Rio Tinto Group (NYSE:RIO)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
6 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$73.00 (17.0% Upside)

About Rio Tinto Group

Rio Tinto Group logoRio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. The Iron Ore segment engages in the iron ore mining, and salt and gypsum production in Western Australia. The Aluminum segment is involved in bauxite mining; alumina refining; and aluminium smelting. More about Rio Tinto Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/18/2025JPMorgan Chase & Co.Initiated CoverageOverweight
2/28/2025Clarkson CapitalUpgradeStrong-Buy
1/6/2025Jefferies Financial GroupLower Price TargetBuy ➝ Buy$83.00 ➝ $73.00
10/16/2024MacquarieReiterated RatingOutperform ➝ Neutral
10/2/2024Berenberg BankUpgradeHold ➝ Buy
7/31/2024Royal Bank of CanadaUpgradeHold
7/23/2024Hsbc Global ResUpgradeStrong-Buy
7/23/2024HSBCUpgradeHold ➝ Buy
6/27/2024Berenberg BankDowngradeBuy ➝ Hold
5/20/2024CitigroupDowngradeBuy ➝ Neutral

#10 - Nokia Oyj (NYSE:NOK)

Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$5.85 (12.6% Upside)

About Nokia Oyj

Nokia Oyj logoNokia Oyj provides mobile, fixed, and cloud network solutions worldwide. The company operates through four segments: Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. The company provides fixed networking solutions, such as fiber and copper-based access infrastructure, in-home Wi-Fi solutions, and cloud and virtualization services; IP networking solutions, including IP access, aggregation, and edge and core routing for residential, mobile, enterprise and cloud applications; optical networks solutions that provides optical transport networks for metro, regional, and long-haul applications, and subsea applications; and submarine networks for undersea cable transmission. More about Nokia Oyj
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
2/21/2025JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$6.35 ➝ $6.30
1/16/2025The Goldman Sachs GroupDowngradeNeutral ➝ Sell$3.60
1/6/2025Craig HallumBoost Price TargetBuy ➝ Buy$6.00 ➝ $7.00
12/9/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$4.35 ➝ $6.35
10/21/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$4.36 ➝ $4.35
10/18/2024DanskeUpgradeHold ➝ Buy
10/18/2024Northland SecuritiesReiterated RatingOutperform ➝ Outperform$6.50 ➝ $6.50
10/17/2024Craig HallumUpgradeHold ➝ Strong-Buy
9/4/2024Northland SecuritiesReiterated RatingOutperform ➝ Outperform$6.00 ➝ $6.50
4/16/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$4.39 ➝ $4.26

#11 - United Therapeutics (NASDAQ:UTHR)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
9 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$388.25 (26.0% Upside)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. More about United Therapeutics
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
2/27/2025HC WainwrightReiterated RatingBuy ➝ Buy$425.00 ➝ $425.00
1/8/2025UBS GroupBoost Price TargetBuy ➝ Buy$415.00 ➝ $475.00
11/1/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$243.00 ➝ $302.00
10/31/2024LADENBURG THALM/SH SHBoost Price TargetBuy ➝ Buy$319.00 ➝ $344.00
10/31/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$575.00 ➝ $600.00
10/31/2024HC WainwrightBoost Price TargetBuy ➝ Buy$400.00 ➝ $425.00
10/31/2024ArgusBoost Price TargetBuy ➝ Buy$360.00 ➝ $400.00
10/21/2024TD CowenBoost Price TargetBuy ➝ Buy$350.00 ➝ $400.00
9/23/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$315.00 ➝ $432.00
8/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$400.00 ➝ $575.00

#12 - Telefônica Brasil (NYSE:VIV)

Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$9.97 (13.6% Upside)

About Telefônica Brasil

Telefônica Brasil logoTelefônica Brasil SA, together with its subsidiaries, operates as a mobile telecommunications company in Brazil. Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G, as well as mobile value-added and wireless roaming services. More about Telefônica Brasil
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/3/2025BarclaysUpgradeEqual Weight ➝ Overweight$11.80 ➝ $11.50
2/27/2025ScotiabankLower Price TargetSector Perform ➝ Sector Perform$10.40 ➝ $9.20
12/19/2024The Goldman Sachs GroupLower Price TargetBuy ➝ Buy$10.60 ➝ $9.20
12/9/2024New Street ResearchDowngradeBuy ➝ Neutral
11/25/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$11.50 ➝ $11.80
9/20/2024ScotiabankBoost Price TargetSector Perform ➝ Sector Perform$9.20 ➝ $10.40
8/1/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$11.00 ➝ $11.50
7/11/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight
5/9/2024BarclaysLower Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $12.00
4/23/2024BarclaysLower Price TargetEqual Weight ➝ Equal Weight$13.50 ➝ $13.00

#13 - Novo Nordisk A/S (NYSE:NVO)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
7 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$145.25 (107.0% Upside)

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. More about Novo Nordisk A/S
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/13/2025Kepler Capital MarketsUpgradeHold ➝ Buy
3/3/2025Stifel NicolausDowngradeBuy ➝ Hold
2/12/2025Morgan StanleyInitiated CoverageEqual Weight
1/8/2025UBS GroupUpgradeSell ➝ Buy
1/6/2025Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
12/23/2024BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$156.00 ➝ $105.00
12/2/2024BNP ParibasUpgradeStrong-Buy
11/6/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
10/17/2024BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$160.00 ➝ $156.00
10/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00

#14 - Agnico Eagle Mines (NYSE:AEM)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$95.78 (11.2% Downside)

About Agnico Eagle Mines

Agnico Eagle Mines logoAgnico Eagle Mines Limited, a gold mining company, exploration, development, and production of precious metals. It explores for gold. The company's mines are located in Canada, Australia, Finland and Mexico, with exploration and development activities in Canada, Australia, Europe, Latin America, and the United States. More about Agnico Eagle Mines
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/21/2025National Bank FinancialUpgradeStrong-Buy
3/19/2025Stifel CanadaUpgradeStrong-Buy
2/19/2025TD SecuritiesLower Price TargetBuy$108.00 ➝ $106.00
2/11/2025Royal Bank of CanadaBoost Price TargetOutperform$96.00 ➝ $105.00
2/4/2025Raymond JamesSet Price TargetOutperform ➝ Outperform$105.00
1/21/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$103.00 ➝ $105.00
1/7/2025Jefferies Financial GroupBoost Price TargetHold ➝ Hold$85.00 ➝ $88.00
10/4/2024Jefferies Financial GroupBoost Price TargetHold ➝ Hold$68.00 ➝ $85.00
9/17/2024UBS GroupInitiated CoverageBuy$95.00
9/10/2024Royal Bank of CanadaBoost Price TargetOutperform$80.00 ➝ $87.00

#15 - EMCOR Group (NYSE:EME)

Consensus Rating
Moderate Buy
Rating Score
2.5
Ratings Breakdown
3 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$497.25 (31.1% Upside)

About EMCOR Group

EMCOR Group logoEMCOR Group, Inc provides construction and facilities, building, and industrial services in the United States and the United Kingdom. It offers design, integration, installation, start-up, operation, and maintenance services related to power transmission, distribution, and generation systems; energy solutions; premises electrical and lighting systems; process instrumentation; low-voltage systems; voice and data communications systems; roadway and transit lighting, signaling, and fiber optic lines; computerized traffic control systems, and signal and communication equipment; heating, ventilation, air conditioning, refrigeration, and geothermal solutions; clean-room process ventilation systems; fire protection and suppression systems; plumbing, process, and high-purity piping systems; controls and filtration systems; water and wastewater treatment systems; central plant heating and cooling systems; crane and rigging services; millwright services; and steel fabrication, erection, and welding services. More about EMCOR Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
2/27/2025Stifel NicolausLower Price TargetBuy ➝ Buy$600.00 ➝ $514.00
11/22/2024Northcoast ResearchInitiated CoverageBuy$600.00
11/22/2024The Goldman Sachs GroupInitiated CoverageSell$445.00
11/15/2024Stifel NicolausInitiated CoverageBuy$600.00
7/26/2024DA DavidsonBoost Price TargetBuy ➝ Buy$410.00 ➝ $430.00
3/22/2024DA DavidsonReiterated RatingBuy ➝ Buy$375.00
1/10/2024KeyCorpInitiated CoverageSector Weight
2/24/2023DA DavidsonBoost Price TargetBuy$165.00 ➝ $188.00
11/4/2022KeyCorpBoost Price TargetOverweight$135.00 ➝ $160.00
11/1/2022DA DavidsonBoost Price Target$165.00

#16 - Regency Centers (NASDAQ:REG)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
9 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$78.00 (7.7% Upside)

About Regency Centers

Regency Centers logoRegency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. More about Regency Centers
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/26/2025Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$80.00 ➝ $79.00
1/29/2025Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$81.00 ➝ $80.00
1/8/2025MizuhoBoost Price TargetOutperform ➝ Outperform$78.00 ➝ $80.00
12/24/2024Evercore ISILower Price TargetIn-Line ➝ In-Line$78.00 ➝ $77.00
11/27/2024BTIG ResearchBoost Price TargetBuy ➝ Buy$72.00 ➝ $79.00
11/4/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$77.00 ➝ $80.00
10/31/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$71.00 ➝ $78.00
10/29/2024Evercore ISIUpgradeHold ➝ Strong-Buy
10/25/2024KeyCorpInitiated CoverageOverweight$80.00
10/24/2024KeyCorpUpgradeStrong-Buy

#17 - ASML (NASDAQ:ASML)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
9 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$937.00 (35.7% Upside)

About ASML

ASML logoASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems for chipmakers. It offers advanced semiconductor equipment systems, including lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. More about ASML
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/30/2025JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$1,148.00 ➝ $1,100.00
1/30/2025DZ BankUpgradeHold ➝ Buy
1/13/2025Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$790.00 ➝ $860.00
12/3/2024BNP ParibasInitiated CoverageOutperform$858.00
11/29/2024Sanford C. BernsteinLower Price TargetOutperform ➝ Outperform$815.00 ➝ $767.00
10/21/2024Sanford C. BernsteinLower Price TargetOutperform ➝ Outperform$1,052.00 ➝ $815.00
10/17/2024Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$1,000.00 ➝ $790.00
10/17/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$1,207.00 ➝ $1,148.00
10/11/2024SusquehannaLower Price TargetPositive ➝ Positive$1,300.00 ➝ $1,100.00
10/9/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$1,202.00 ➝ $1,207.00

#18 - Mplx (NYSE:MPLX)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
8 Buy Ratings, 1 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$54.00 (0.6% Upside)

About Mplx

Mplx logoMPLX LP engages in the operation of midstream energy infrastructure and logistics assets, and distribution fuels services. It operates through the Logistics and Storage (L&S) and Gathering and Processing (G&P) segments. The Logistics and Storage segment transports, stores, distributes, and markets crude oil, asphalt, refined petroleum products, and water. More about Mplx
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/17/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $58.00
3/14/2025BarclaysBoost Price TargetOverweight ➝ Overweight$52.00 ➝ $55.00
3/11/2025Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $62.00
2/6/2025Raymond JamesBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00
2/6/2025Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $59.00
1/13/2025BarclaysBoost Price TargetOverweight ➝ Overweight$49.00 ➝ $52.00
12/18/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$53.00 ➝ $54.00
11/19/2024Truist FinancialBoost Price TargetBuy ➝ Buy$48.00 ➝ $55.00
11/18/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $52.00
11/15/2024UBS GroupBoost Price TargetBuy ➝ Buy$51.00 ➝ $55.00

#19 - Equinor ASA (NYSE:EQNR)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
11 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$28.10 (7.4% Upside)

About Equinor ASA

Equinor ASA logoEquinor ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and other forms of energy in Norway and internationally. It operates through Exploration & Production Norway; Exploration & Production International; Exploration & Production USA; Marketing, Midstream & Processing; Renewables; and Other segments. More about Equinor ASA
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/17/2025Morgan StanleyLower Price TargetOverweight ➝ Overweight$30.90 ➝ $28.20
2/10/2025Hsbc Global ResUpgradeStrong-Buy
2/10/2025HSBCUpgradeHold ➝ Buy
2/6/2025Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform
2/6/2025DZ BankUpgradeHold ➝ Buy
2/6/2025DanskeUpgradeHold ➝ Buy
2/6/2025Pareto SecuritiesUpgradeHold ➝ Buy
2/6/2025Nordea Equity ResearchUpgradeHold ➝ Buy
1/7/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$25.80 ➝ $30.90
12/9/2024JPMorgan Chase & Co.UpgradeUnderweight ➝ Overweight

#20 - JD.com (NASDAQ:JD)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
12 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$45.64 (6.4% Upside)

About JD.com

JD.com logoJD.com, Inc operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. More about JD.com
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/12/2025SusquehannaReiterated RatingNeutral ➝ Neutral$35.00 ➝ $45.00
3/7/2025UBS GroupSet Price Target$51.00
3/7/2025UBS GroupReiterated RatingBuy ➝ Buy
3/7/2025Sanford C. BernsteinReiterated RatingOutperform ➝ Outperform
3/7/2025MizuhoBoost Price TargetOutperform ➝ Outperform$43.00 ➝ $50.00
3/7/2025JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$50.00 ➝ $55.00
3/7/2025BenchmarkBoost Price TargetBuy ➝ Buy$47.00 ➝ $58.00
2/28/2025BarclaysBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $55.00
2/12/2025Dbs BankUpgradeStrong-Buy
12/9/2024Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$43.00 ➝ $46.00

More Investing Slideshows: